Wang, D., Jiang, Y., Yang, X., Wei, Q., & Wang, H. (2018). 6-Shogaol reduces progression of experimental endometriosis in vivo and in vitro via regulation of VGEF and inhibition of COX-2 and PGE2-mediated inflammatory responses. Korean Journal of Physiology & Pharmacology, 22(6), 627. https://doi.org/10.4196/kjpp.2018.22.6.627
Chicago Style (17th ed.) CitationWang, Dan, Yiling Jiang, Xiaoxin Yang, Qiong Wei, and Huimin Wang. "6-Shogaol Reduces Progression of Experimental Endometriosis in Vivo and in Vitro via Regulation of VGEF and Inhibition of COX-2 and PGE2-mediated Inflammatory Responses." Korean Journal of Physiology & Pharmacology 22, no. 6 (2018): 627. https://doi.org/10.4196/kjpp.2018.22.6.627.
MLA (9th ed.) CitationWang, Dan, et al. "6-Shogaol Reduces Progression of Experimental Endometriosis in Vivo and in Vitro via Regulation of VGEF and Inhibition of COX-2 and PGE2-mediated Inflammatory Responses." Korean Journal of Physiology & Pharmacology, vol. 22, no. 6, 2018, p. 627, https://doi.org/10.4196/kjpp.2018.22.6.627.